Sotac Pharmaceuticals (SOTAC.NS) Hisse Fiyat

Sotac Pharmaceuticals Ltd. engages in developing and manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-04-13. The firm specializes in the manufacturing of a range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-Lactam syrup, and external preparations. The company is engaged in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Its therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, and Cephalosporin. Its subsidiaries include SOTAC Healthcare Private Limited (SOTAC Healthcare), SOTAC Research Private Limited (SOTAC Research), and SOTAC Lifescience Private Limited.